JP2020532745A5 - - Google Patents

Download PDF

Info

Publication number
JP2020532745A5
JP2020532745A5 JP2020513919A JP2020513919A JP2020532745A5 JP 2020532745 A5 JP2020532745 A5 JP 2020532745A5 JP 2020513919 A JP2020513919 A JP 2020513919A JP 2020513919 A JP2020513919 A JP 2020513919A JP 2020532745 A5 JP2020532745 A5 JP 2020532745A5
Authority
JP
Japan
Prior art keywords
level
biomarker
group
determining
biomarkers
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
JP2020513919A
Other languages
English (en)
Japanese (ja)
Other versions
JP2020532745A (ja
Filing date
Publication date
Application filed filed Critical
Priority claimed from PCT/IB2018/001117 external-priority patent/WO2019048927A2/en
Publication of JP2020532745A publication Critical patent/JP2020532745A/ja
Publication of JP2020532745A5 publication Critical patent/JP2020532745A5/ja
Pending legal-status Critical Current

Links

JP2020513919A 2017-09-05 2018-09-05 子癇前症と関連したバイオマーカーを検出するための方法及び装置 Pending JP2020532745A (ja)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US201762554471P 2017-09-05 2017-09-05
US62/554,471 2017-09-05
PCT/IB2018/001117 WO2019048927A2 (en) 2017-09-05 2018-09-05 METHODS AND DEVICES FOR DETECTION OF BIOMARKERS ASSOCIATED WITH PRECLAMPSIA

Publications (2)

Publication Number Publication Date
JP2020532745A JP2020532745A (ja) 2020-11-12
JP2020532745A5 true JP2020532745A5 (enExample) 2021-10-14

Family

ID=64184119

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2020513919A Pending JP2020532745A (ja) 2017-09-05 2018-09-05 子癇前症と関連したバイオマーカーを検出するための方法及び装置

Country Status (8)

Country Link
US (1) US20200271660A1 (enExample)
EP (1) EP3679380A2 (enExample)
JP (1) JP2020532745A (enExample)
CN (1) CN111630387A (enExample)
BR (1) BR112020004390A2 (enExample)
CA (1) CA3074808A1 (enExample)
MA (1) MA50123A (enExample)
WO (1) WO2019048927A2 (enExample)

Families Citing this family (19)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US11401552B2 (en) 2015-08-06 2022-08-02 University Of Utah Research Foundation Methods of identifying male fertility status and embryo quality
CN114599800A (zh) * 2019-08-15 2022-06-07 华盛顿州立大学 不育症诊断方法和试剂盒
CN110794136A (zh) * 2019-11-26 2020-02-14 中国人民武装警察部队特色医学中心 长链脂肪酸辅酶a连接酶1在诊断或预测子痫前期中的应用
KR102302742B1 (ko) * 2019-12-31 2021-09-15 의료법인 성광의료재단 임신중독증 진단용 바이오마커 조성물 및 이의 용도
EP4165416A1 (en) * 2020-06-10 2023-04-19 Board of Regents, The University of Texas System Method for determining risk of pre-term birth
EP4232823A1 (en) * 2020-10-26 2023-08-30 Institut National de la Santé et de la Recherche Médicale Combination of biomarkers of preterm delivery
CN112630436A (zh) * 2021-01-25 2021-04-09 安士(广州)医疗科技有限公司 一种定量检测tex101浓度的荧光试剂条的制备方法及其应用
WO2022171318A1 (en) * 2021-02-12 2022-08-18 Ipremom Pregnancy Healthcare Diagnostics, S.L. In vitro method for determining the risk of suffering from preeclampsia
CN113406326B (zh) * 2021-06-01 2022-08-26 大连医科大学 一种用于预测子痫前期的生物学标志物及其应用
EP4347886A1 (en) 2021-06-03 2024-04-10 Inherent Biosciences, Inc. Dna methylation analysis to identify cell type
WO2022255401A1 (ja) * 2021-06-03 2022-12-08 国立大学法人 東京大学 Erk-mapk経路の異常な活性化に伴い発現する疾患マーカー
CN114350805A (zh) * 2022-01-14 2022-04-15 中国人民解放军陆军军医大学第一附属医院 Ablim1作为胶质瘤分子标志物的应用
CN114822682B (zh) * 2022-04-12 2023-07-21 苏州市立医院 与早发型重度子痫前期发生相关的基因组合及其应用
CN115044669B (zh) * 2022-06-27 2023-05-16 山东第一医科大学附属省立医院(山东省立医院) 一种血浆lncRNA检测试剂盒及其应用
CN115873943B (zh) * 2023-02-13 2024-03-29 山东大学 骨形态发生蛋白2在子痫前期诊断、预防和治疗中的应用
CN117192096A (zh) * 2023-09-18 2023-12-08 上海交通大学医学院附属仁济医院 靶向抑制羊膜adamts4的化合物在制备筛选早产防治的药物中的用途
KR20250079482A (ko) * 2023-11-27 2025-06-04 의료법인 성광의료재단 임신 초기 임신중독증 예측 및 진단을 위한 질환 특이적인 바이오마커 및 그의 용도
KR20250079483A (ko) * 2023-11-27 2025-06-04 의료법인 성광의료재단 임신 중기 임신중독증 예측 및 진단을 위한 질환 특이적인 바이오마커 및 그의 용도
CN118275677B (zh) * 2024-06-03 2024-08-09 山东大学 检测erap2的试剂在制备预测poi预后情况的产品中的应用

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP1946121A2 (en) * 2005-10-27 2008-07-23 Yale University, Inc. Urinary proteomic biomarker patterns in preeclampsia
US7790463B2 (en) * 2006-02-02 2010-09-07 Yale University Methods of determining whether a pregnant woman is at risk of developing preeclampsia
US20110171650A1 (en) * 2008-09-16 2011-07-14 University Of Pittsburgh-Of The Commonwealth System Of Higher Education Gene expression related to preeclampsia
CN104704364B (zh) * 2012-06-15 2018-12-04 韦恩州立大学 用于先兆子痫和/或hellp综合征的预测或早期检测的生物标记物测试
US9907833B2 (en) * 2013-07-25 2018-03-06 University Of Florida Research Foundation, Incorporated Use of relaxin to treat placental syndromes
US20170097358A1 (en) * 2014-03-21 2017-04-06 Igenomix S.L. Early detection of preeclampsia

Similar Documents

Publication Publication Date Title
JP2020532745A5 (enExample)
US20240229150A1 (en) Method for breast cancer recurrence prediction under endocrine treatment
EP3179393B1 (en) Gene expression profile algorithm and test for determining prognosis of prostate cancer
JP2020031642A (ja) 遺伝子発現を用いた前立腺癌の予後を定量化する方法
JP2018514219A5 (enExample)
RU2008150483A (ru) Способ выявления
JP2012517241A5 (enExample)
US20140228241A1 (en) Method for predicting the response to chemotherapy in a patient suffering from or at risk of developing recurrentbreast cancer
KR102376220B1 (ko) 전립선암에서 후기 임상적 종점을 평가하기 위한 알고리즘 및 방법
US20170283877A1 (en) Biomarkers and uses thereof in prognosis and treatment strategies for right-side colon cancer disease and left-side colon cancer disease
US20150322533A1 (en) Prognosis of breast cancer patients by monitoring the expression of two genes
CN110520543A (zh) 确定胃癌对西妥昔单抗敏感性的系统和方法
CN110494570A (zh) 确定癌症对卡仑尼替星敏感性的系统和方法
RU2671557C1 (ru) Набор реагентов для определения риска возникновения рецидива онкологических заболеваний молочной железы
TWI612140B (zh) 利用長鏈非編碼核醣核酸之評分方法以預測骨髓化生不良症候群病患之預後
AU2011234573B8 (en) Method for breast cancer recurrence prediction under endocrine treatment
WO2018231085A1 (ru) Способ определения риска возникновения рецидива онкологических заболеваний молочной железы
AU2015204286A1 (en) Prognosis of breast cancer patients by monitoring the expression of two genes
HK1237068B (en) Gene expression profile algorithm and test for determining prognosis of prostate cancer
HK1181817B (en) Method for breast cancer recurrence prediction under endocrine treatment